2-Phenylglycine

2-Phenylglycine (CAS No.: 2835-06-5) is a phenyl-substituted amino acid derivative widely employed as a versatile intermediate and structural building block in biomedical research and drug discovery. It serves as a precursor in the synthesis of diverse bioactive peptides and small-molecule therapeutics, including inhibitors targeting viral enzymes such as hepatitis C virus NS3 protease, as well as compounds with antimicrobial and fungicidal properties. Biologically, 2-Phenylglycine has been identified as an endogenous metabolite present in human breast milk during the early lactation period, suggesting a potential role in neonatal metabolic regulation and maternal–infant biochemical interactions, although its precise physiological functions and molecular targets remain incompletely characterized. Mechanistically, its relevance in research is primarily associated with its incorporation into peptide frameworks and its participation in amino acid-related metabolic pathways rather than direct modulation of a defined signaling cascade. In vitro studies of derivatives incorporating this scaffold often demonstrate activity in the nanomolar to micromolar range depending on the target and molecular context, supporting its utility in structure-based drug design and optimization. Consequently, 2-Phenylglycine is frequently utilized in chemical biology, metabolomics, and medicinal chemistry applications, including pathway analysis, biomarker exploration, and the development of enzyme inhibitors, with experimental concentrations or dosing strategies varying according to specific assay systems and research objectives.